Targeted Therapy in Cardiovascular Disease: A Precision Therapy Era
Targeted therapy refers to exploiting the specific therapeutic drugs against the pathogenic molecules (a protein or a gene) or cells. The drug specifically binds to disease-causing molecules or cells without affecting normal tissue, thus enabling personalized and precision treatment. Initially, ther...
Main Authors: | Mengda Xu, Jiangping Song |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.623674/full |
Similar Items
-
Polymer Nanoparticles and Nanomotors Modified by DNA/RNA Aptamers and Antibodies in Targeted Therapy of Cancer
by: Veronika Subjakova, et al.
Published: (2021-01-01) -
Aptamers used for biosensors and targeted therapy
by: Yi Ning, et al.
Published: (2020-12-01) -
Neoglycoconjugates for the delivery of nucleic acids into eucaryotic cells
by: M. A. Maslov, et al.
Published: (2015-08-01) -
Advances in Cardiovascular Toxicity Associated with Targeted Therapy for Breast Cancer
by: WANG Yan, et al.
Published: (2021-05-01) -
The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively
by: Wen‐Qian Li, et al.
Published: (2021-07-01)